股息配發率   玩股撇步(動畫小學堂)

  • 現金殖利率: 3.75%、總殖利率: 3.75%、5年平均現金配發率: 105.79%
  • 要留意資產負債表的未分配盈餘和配息能力, 如果為負值, 可能會無法發放股利
  • 股利有2個稅要支出, 分別是綜合所得稅和健保補充保費(單筆股利達2萬元以上, 課2.11%)
EPS YoY現金股利 YoY股票股利 YoY現金配發率 YoY股票配發率 YoY全部配發率 YoY
2025 (5)1.002.041.10-19.120.000110.00-20.740.000110.00-20.74
2024 (4)0.98-56.641.36-32.00.000138.7856.820.000138.7856.82
2023 (3)2.2614.142.001.520.00088.50-11.060.00088.50-11.06
每股盈餘-近8季
EPS QoQ YoY本業EPS QoQ YoY累計EPS QoQ YoY
26Q1 (8)0.13-65.79160.00.27-51.7935.00.13-87.0160.0
25Q4 (7)0.388.5740.740.5633.33250.01.0056.25-0.99
25Q3 (6)0.3559.09-37.50.42100.0-17.650.64128.57-13.51
25Q2 (5)0.22340.029.410.215.0-8.70.28460.055.56
25Q1 (4)0.05-81.480.00.2025.00.00.05-95.050.0
24Q4 (3)0.27-51.790.00.16-68.630.01.0136.490.0
24Q3 (2)0.56229.410.00.51121.740.00.74311.110.0
24Q2 (1)0.170.00.00.230.00.00.180.00.0
年/月營收月增率(%)去年同期年增率(%)累計營收累計營收年增率(%)近三月累計營收存貨銷售比自結稅前EPS自結稅前累計EPS備註(年增率變動50%需說明原因)
2026/43.04-47.2521.814.6516.7511.5N/A-
2026/35.77114.763.3511.615.4911.60.8-
2026/22.69-14.6222.755.8330.6710.610.88-
2026/13.15-34.138.283.1538.2811.860.79-
2025/124.7821.19-1.7343.9822.1812.090.89-
2025/113.9416.6832.6239.2125.9112.60.86-
2025/103.38-36.0242.1935.2725.211.50.94-
2025/95.2886.09.131.8923.6410.991.0-
2025/82.84-1.2310.6326.6126.9911.051.0-
2025/72.87-46.1229.0823.7729.2811.220.98-
2025/65.3376.8646.5220.929.310.850.83-
2025/53.0220.68-21.7415.5624.311.10.81-
2025/42.5-55.2313.9612.5544.7710.270.87-
2025/35.58155.07151.0610.0555.2110.050.98主係因本月有驗收大型儀器設備,而去年同期並無驗收大型儀器設備,故使得本月營收較去年同期月份大幅增加。
2025/22.19-3.8230.814.465.059.331.05-
2025/12.28-53.17-11.662.28-11.6610.110.97-
2024/124.8663.5632.136.0-7.1510.210.87-
2024/112.9725.09-22.1131.14-11.2610.190.87-
2024/102.38-50.91-66.2428.17-9.949.780.9主係因去年同期有驗收大型儀器設備,而本月並無驗收大型儀器設備,故使得本月營收較去年同期月份大幅減少。
2024/94.8488.6281.2725.796.399.630.74主係因本月有驗收大型儀器設備,而去年同期並無驗收大型儀器設備,故使得本月營收較去年同期月份大幅增加。
2024/82.5715.235.220.95-2.878.430.84-
2024/72.23-38.84-1.8818.39-3.99.720.73-
2024/63.64-5.54-12.616.16-4.179.690.69-
2024/53.8575.7455.612.52-1.48.270.8主係因本月有驗收大型儀器設備,而去年同期並無驗收大型儀器設備,故使得本月營收較去年同期月份大幅增加。
2024/42.19-1.39-1.198.67-15.226.091.09-
2024/32.2232.9-42.516.47-19.116.47N/A-
2024/21.67-35.05-15.674.252.787.93N/A-
2024/12.58-29.9619.822.5819.8210.07N/A-
2023/123.68-3.55-4.1438.7730.3514.53N/A-
2023/113.81-45.7860.8735.0935.4613.52N/A主係因本月有驗收大型儀器設備,而去年同期並無驗收大型儀器設備,故使得本月營收較去年同期月份大幅增加。
2023/107.04163.57196.1931.2832.912.14N/A主係因本月有驗收大型儀器設備,而去年同期並無驗收大型儀器設備,故使得本月營收較去年同期大幅增加。
2023/92.679.47-27.424.2414.577.38N/A-
2023/82.447.464.4421.5723.48.87N/A-
2023/72.27-45.534.9319.1326.328.91N/A-
2023/64.1768.18117.816.8629.888.86N/A主係因本月有驗收大型儀器設備,而去年同期並無驗收大型儀器設備,故使得本月營收較去年同期月份大幅增加。
2023/52.4811.59-12.3412.714.698.56N/A-
2023/42.22-42.631.5910.2223.968.07N/A-
2023/33.8794.9671.478.032.028.0N/A主係因本月有驗收大型儀器設備,而去年同期並無驗收大型儀器設備,故使得本月營收較去年同期月分大幅增加。
2023/21.98-7.7123.284.138.637.97N/A-
2023/12.15-43.98-2.092.15-2.098.36N/A-
2022/123.8461.86-19.2429.7421.838.59N/A-
2022/112.37-0.179.2925.9131.778.42N/A-
2022/102.38-35.427.7323.5334.558.39N/A-
2022/93.6857.581.9321.1635.368.17N/A主係因本月有驗收大型儀器設備,而去年同期並無驗收大型儀器設備,故使得本月營收較去年同期月份大幅增加。
2022/82.337.9760.9617.4828.456.41N/A主係因110年10月份併購富康公司後產生之綜效,使得本月營收較去年同期大幅增加。
2022/72.1613.0664.0515.1524.576.9N/A主係因110年10月份併購富康公司後產生之綜效,使得本月營收較去年同期大幅增加。
2022/61.91-32.3134.8312.9819.776.92N/A-
2022/52.8329.3498.0911.0717.57.27N/A主係因本月受疫情影響藥品銷貨收入大幅成長,故使得本月營收較去年同期月份大幅增加。
2022/42.18-3.1737.88.253.136.05N/A-
2022/32.2640.1825.76.06-5.446.06N/A-
2022/21.61-26.71-41.633.81-17.548.56N/A-
2022/12.2-53.7918.192.218.199.12N/A-
2021/124.75119.07109.6524.41-4.438.78N/A主係因本月有驗收大型儀器設備,而去年同期並無驗收大型儀器設備,故使得本月營收較去年同期月份大幅增加。
2021/112.1716.6641.319.66-15.556.05N/A-
2021/101.86-7.9920.4317.49-19.565.33N/A-
2021/92.0239.35-42.1815.63-22.624.79N/A-
2021/81.4510.04-17.6613.61-18.524.19N/A-
2021/71.32-7.07-56.9812.16-18.634.16N/A主係因去年同期有驗收大型儀器設備,而本月並無驗收大型儀器設備,故使得本月營收較去年同期月份大幅減少。
2021/61.42-0.55-41.9210.84-8.730.0N/A-
2021/51.43-10.0214.19.42-0.140.0N/A-

股利相關資訊

免責聲明

本網站所有資料僅供參考,如使用者依本資料交易發生交易損失需自行負責,本網站對資料內容錯誤﹑更新延誤不負任何責任。